4DMedical Limited

ASX (AUD): 4DMedical Limited (4DX)

Last Price

0.495

Today's Change

+0.005 (1.02%)

Day's Change

0.485 - 0.505

Trading Volume

497,153

Profile
4DX

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Andreas Fouras M.A.I.C.D., Ph.D. Dr. Andreas Fouras M.A.I.C.D., Ph.D.

Full Time Employees:  145 145

IPO Date:  2020-08-07 2020-08-07

CIK: 

ISIN:  AU0000095416 AU0000095416

CUSIP: 

Beta:  1.34 1.34

Last Dividend:  0.00 0.00

Dcf Diff:  0.77 0.77

Dcf:  -0.28 -0.28

Description

4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.

Address

Melbourne Connect,
Carlton, VIC 3053, AU

61 3 9545 5940

http://www.4dmedical.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment